Post-translational modifications of expanded polyglutamine proteins: Impact on neurotoxicity

65Citations
Citations of this article
103Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Polyglutamine diseases are a family of nine neurodegenerative disorders caused by expansion in different genes of a CAG triplet repeat stretch, which encodes an elongated polyglutamine tract. This polyglutamine tract is thought to confer a toxic gain of function to the bearing proteins, which leads to late onset and progressive loss of neurons in specific regions of the central nervous system. The mechanisms underlying specificity for neuronal vulnerability remain enigmatic. One explanation is that the polyglutamine tract is not the only determinant of neurodegeneration and that protein context and post-translational events may also be crucial for pathogenesis. Here, we review how post-translational modifications of the polyglutamine proteins contribute to modulate neurotoxicity. © The Author 2009. Published by Oxford University Press. All rights reserved.

Cite

CITATION STYLE

APA

Pennuto, M., Palazzolo, I., & Poletti, A. (2009). Post-translational modifications of expanded polyglutamine proteins: Impact on neurotoxicity. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddn412

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free